2 recruiting, 1 active not recruiting, 1 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 2, Active not recruiting 1, Completed 1 |
Follow D: new trials by email Literature Review of D trials Research Report on D
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level Daratumumab, Lenalidomide, Dexamethasone - Multiple Myeloma (MM), Plasma Cell Leukemia (PCL) | Phase 3 | Recruiting | University of Leeds | 1226 | 2026-07-01 | 2026-07-15 |
| A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003 Pomalidomide Capsules, Bortezomib for Injection, Daratumumab Injection (Subcutaneous Injection) - Relapsed or Refractory Multiple Myeloma | Phase 3 | Recruiting | Innovent Biologics (Suzhou) Co. Ltd. | 255 | 2026-06-11 | 2026-09-17 |
| Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort bedaquiline, delamanid, linezolid - Drug-resistant Tuberculosis, Pulmonary Tuberculosis | Phase 3 | Active not recruiting | Huashan Hospital | 120 | 2024-11-27 | 2025-09-02 |
| Efficacy and Safety of Dexketoprofen/Vitamin B Vs Dexketoprofen for Post-traumatic Cervical Sprain Grade I-II Dexketoprofen/Vitamin B, Dexketoprofen - Acute Low Back Pain | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 174 | 2021-11-23 | 2024-11-13 |
Multiple Myeloma (2) · Frailty (1) · Leukemia, Plasma Cell (1) · Neoplasms, Plasma Cell (1) · Recurrence (1) · Tuberculosis, Multidrug-Resistant (1) · Tuberculosis, Pulmonary (1)
Huashan Hospital (1) · Innovent Biologics (Suzhou) Co. Ltd. (1) · Laboratorios Silanes S.A. de C.V. (1) · University of Leeds (1)
China (2) · Mexico (1) · United Kingdom (1)
Adelfia Urenda Quezada, M.D (1) · Charlotte Pawlyn (1) · Gordon Cook (1) · Juan B Alcocer Herrera, M.D (1)